Yorktown Management & Research Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Yorktown Management & Research Company's PFE Position: Q3 2020 in Review
Yorktown Management & Research Company sold out of Pfizer (PFE) in Q3 2020, closing a stake of 9,012 shares — an estimated $280K sold.
Yorktown Management & Research Company first reported a position in PFE in Q1 2015 and held it in 16 quarters. The position peaked at $3.33M in Q3 2015. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.
- Yorktown Management & Research Company reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
- Yorktown Management & Research Company sold 9,012 Pfizer shares in Q3 2020, an estimated $280K.
- Yorktown Management & Research Company first reported a position in Pfizer in Q1 2015 and held it in 16 quarters.
- Yorktown Management & Research Company's Pfizer position peaked at $3.33M in Q3 2015.
- 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.
Based on Yorktown Management & Research Company's 13F filing for Q3 2020, filed 6 Nov 2020.